VRC 008 (05-I-0148)

A Phase I Clinical Trial of a Prime-Boost HIV-1 Vaccination Schedule: Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, Followed by Multiclade Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) May 01, 2005
VRC-HIVDNA016-00-VP,VRC-HIVADV014-00-VP DNA env A, env b, env C, gag B, pol B, nef B; Ad5 env A, env B, env C, gag B, pol B
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA 40